Top of page
Global Site Navigation

School of Medical and Health Sciences

Local Section Navigation

Help us improve our content by rating this page.

Page rating system

Please leave a comment about your rating so we can better understand how we might improve the page.

You are here: Main Content

Dr Carlos Aya-Bonilla

Post Doctoral Fellow

Contact Information Telephone: +61 8 6304 2783, Mobile: 61433596038, Email: c.ayabonilla@ecu.edu.au, Campus: Joondalup, Room: JO17.309
Staff Member Details
Telephone: +61 8 6304 2783
Mobile: 61433596038
Email: c.ayabonilla@ecu.edu.au
Campus: Joondalup  
Room: JO17.309  

 

Dr Carlos Aya-Bonilla is a Post Doctoral Fellow in the School of Medical and Health Sciences.

Qualifications

  • Doctor of Philosophy, Griffith University, 2013.

Research

Recent Research Grants

  • Blood Based Biomarkers Predictive of Treatment Response in Melanoma,  Cancer Council of WA Inc,  Grant,  2016 - 2018,  $246,822.
  • Gene expression profiling of circulating tumour cells (CTCs) isolated from metastatic melanoma patients using a microfluidic chip,  Cancer Council of WA Inc,  Grant - Early Career Investigator,  2016 - 2017,  $35,000.
  • Circulating Tumour Cells (CTCs) as biomarkers in metastatic melanoma,  Edith Cowan University,  ECU Early Career Researcher Grant - 2016,  2016 - 2017,  $30,000.
  • Transcriptomic profiling of Circulating Tumour Cells (CTCs) isolated from metastatic melanoma patients,  Edith Cowan University,  School of Medical and Health Sciences Research Grant Scheme 2016,  2016,  $10,000.

Recent Publications (within the last five years)

Journal Articles

  • Aya-Bonilla, C., Marsavela, G., Freeman, J., Lomma, C., Frank, M., Khattak, M., Tarek, M., Millward, M., Warkiani, M., Gray, E., Ziman, M., (2017), Isolation and detection of circulating tumour cells from metastatic melanoma patients using a slanted spiral microfluidic device. Oncotarget, In Press(In Press), 15p..
  • Aya-Bonilla, C., Camilleri, E., Haupt, L., Lea, R., Gandhi, M., Griffiths, L., (2014), In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL). BMC Genomics, 15(1), Article number 390, BioMed Central, DOI: 10.1186/1471-2164-15-390.
  • Aya-Bonilla, C., Torres, J., Muskus, C., Gaviria, GR., Sierra, JC., Sanchez, MS., Cuellar-Ambrosi, F., Garces, JH., Artigas, CG., Mu?eton, CM., Palacio, GV., (2014), Detection of p190BCR-ABL and p210B CR-ABL fusion transcripts in patients with chronic myeloid leukemia (CML) using qualitative RT-PCR [Frecuencia de los transcriptos p190BCR-ABL y p210BCR-ABL en una poblacion colombiana con leucemia mieloide cronica (LMC) usando RT-PCR cualitativa]. Iatreia: revista medica Universidad de Antioquia , 27(4), 398-409, Universidad de Antioquia.
  • Aya-Bonilla, C., Camilleri, E., Benton, M., Haupt, L., Marlton, P., Lea, R., Gandhi, M., Griffiths, L., (2014), Fine mapping of the 15q21 region implicates TP53BP1 and B2M in the lymphomagenesis of follicular and diffuse large B-cell lymphomas. Journal of Carcinogenesis & Mutagenesis, 5(6), Article no. 195, Westlake, USA, Omics Publishing Group, DOI: 10.4172/2157-2518.1000195.
  • Aya-Bonilla, C., Green, M., Camilleri, E., Benton, M., Keane, C., Marlton, P., Lea, R., Gandhi, M., Griffiths, L., (2013), High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to non-hodgkin's lymphoma. Genes Chromosomes and Cancer, 52(5), 467-469, United States, Wiley, DOI: 10.1002/gcc.22044.

Research Student Supervision

Associate Supervisor

  • Master of Science (Human Biology),  Optimisation Of The Isolation And Identification Of Circulating Melanoma Cells
Skip to top of page